Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection

Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi

"LLC Neolab", Tbilisi

Prince Of Wales Hospital - The Chinese University Of Hong Kong, Hong Kong

Queen Mary Hospital, Hong Kong

Punkt Zdrowia Hlebowicz Jakubowski Lekarze Spółka Partnerska, Gdansk

ID Clinic Arkadiusz Pisula, Mysłowice

Punkt Zdrowia Hlebowicz Jakubowski Lekarze Spółka Partnerska, Wroclaw

Arensia Exploratory Medicine Srl Romania in colaborare cu Institutul National de Boli Infectioase, Bucharest

Hospital Clínic de Barcelona, Barcelona

Hospital Universitario Vall d'Hebron, Barcelona

Chia-yi Christian Hospital, Chia-Yi City

Kaohsiung Medical University Chung-ho Memorial Hospital, Kaohsiung City

China Medical University Hospital, Taichung

National Cheng Kung University Hospital, Tainan City

National Taiwan University Hospital, Taipei

King Chulalongkorn Memorial Hospital, Bangkok

Siriraj Hospital, Bangkok

The Hiv Netherlands Australia Thailand Research Collaboration, Bangkok

Srinagarind Hospital, Khon Kaen

Naresuan University Hospital, Phitsanulok

Imperial College Hospital, London

Royal London Hospital, London